To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Participation

Infographic: What is ClinicalTrials.gov?

WhatisClinicalTrials.gov FeatureImage 9Jan2020-01

Editor's Note: This blog was first published in 2014, but with several recent updates to ClinicalTrials.gov search functionality and the 20th anniversary of the site on February 29, we felt a refresh of our infographic was in order. This year, the NIH has issued a Request for Information (through March 14, 2020) to continue to modernize the site, based on broad input. Follow the link provided at the end of this article to submit your feedback on website functionality, information submission processes, and use of data standards.

Many of you—as patients, caregivers, researchers, or curious citizen scientists—may have already visited ClinicalTrials.gov to explore clinical trials. But, for those who haven't, or for those who would just like know more, we thought it might be helpful to look into the site's origins and intentions, as we acknowledge its 20th anniversary this year.

WhatisClinicalTrials.gov Infographic 29Jan2020

Why Was ClinicalTrials.gov Developed?

The Food and Drug Administration Modernization Act of 1997 (FDAMA) stipulated the creation of:

"A registry of clinical trials…of experimental treatments for serious or life-threatening diseases and conditions…which provides a description of the purpose or each experimental drug… Information provided shall consist of eligibility criteria for participation and a point of contact for those wanting to enroll in the trial, and shall be in a form that can be readily understood by members of the public..." Text of FDAMA (PDF)

ClinicalTrials.gov launched three years later in 2000 with just a few thousand trials listed. It has since swelled to include more than 325,857 in 50 states and 209 countries. While it was originally intended to catalog only trials for “serious or life-threatening diseases," newer requirements by the International Committee of Medical Journal Editors (ICMJE) and the Food and Drug Administration Amendments Act of 2007 (FDAAA) have resulted in more trials for more types of diseases being added to ClincialTrials.gov.

Many visitors to ClinicalTrials.gov are patients who use the site to research opportunities to join clinical trials. However, the site was created primarily as a transparency tool to ensure that sponsors disclose their clinical trials publicly. Since 2008, trial results are to be included on ClinicalTrials.gov.

What Information Can Be Found on ClinicalTrials.gov?

In addition to a general explanation of ClinicalTrials.gov and a timeline, the "About ClinicalTrials.gov" infographic highlights some of the key types of information that can be found on the site in a single clinical trial entry. They include the NCT number, the type of intervention, the study's design, the planned outcomes, the eligibility criteria and the results database. Understanding each of these categories and what they mean can help people fully understand what a trial requires from a participant and what the trial is trying to achieve, which in turn, helps people decide about participating in the study.

Do you have any thoughts on how data from the site could be enhanced in order to help people connect with research that may be relevant to them? Please let us know on Twitter or provide your feedback directly through the NIH Request for Information (deadline is March 14).

Blog post originally appeared on LillyPad.

References used for the infographic:

  1. https://clinicaltrials.gov/ct2/about-site/background
  2. https://clinicaltrials.gov/ct2/resources/trends#RegisteredStudiesOverTime
  3. https://clinicaltrials.gov/ct2/about-studies/glossary
  4. https://clinicaltrials.gov/ct2/resources/trends/
  5. https://ippcr.nihtraining.com/handouts/2012/Zarin0305_13.pdf
  6. https://clinicaltrials.gov/ct2/manage-recs/background
Tags: Infographic,

Recent Articles

StudyCoordinatorPatientPartnerThroughClinicalTrials FeatureImage 15Dec2020

Study Coordinator: Patient Partner Through Clinical Trials

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
January 13th, 20217 minute read

Study coordinators are a key part of the clinical trial journey. To learn more about what they do, read our interview with study coordinator, Kelly Roberts.

RandomizationInClinicalTrials FeatureImage 10Dec2020-01

Randomization in Clinical Trials

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
December 15th, 20206 minute read

What is randomization, and why do we use it in clinical research? Read more to uncover the answers to your questions.

CaringForCaregivers FeatureImage 17Nov2020

Caring for Caregivers

Susan Gilchrist headshot square
Susan Gilchrist
November 18th, 20204 minute read

Read more for services and support groups to make life a bit easier for caregivers - the unsung heroes in the clinical trial process.

YourQuestionsAboutAlzheimersAnswered FeatureImage 21Sept2020

Your Questions About Alzheimer’s Research, Answered

Susan Gilchrist headshot square
Susan Gilchrist
November 17th, 20205 minute read

Considering clinical trial participation may feel overwhelming. Here are some answers to common questions about Alzheimer’s and dementia clinical trials to support you through the learning curve.

ListenToTheYouthVoiceForPatientCentricPediatricDrugDevelopment FeatureImage 21Sept2020-01

Listen to the Youth Voice for Patient-Centric Pediatric Drug Development

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
September 24th, 20204 minute read

The patient voice is critical for successful clinical research, for people of all ages. Learn how Lilly’s partnership with iCAN helps us include that voice in research.